Transdermal Drug Delivery System Market Intelligence Report - Global Forecast to 2027

Transdermal Drug Delivery System Market Intelligence Report - Global Forecast to 2027

The Global Transdermal Drug Delivery System Market is projected to reach USD 8,478.05 million by 2027 from USD 6,369.32 million in 2021, at a CAGR 4.88% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Transdermal Drug Delivery System Market size was estimated at USD 2,498.05 million in 2021 and expected to reach USD 2,602.91 million in 2022, at a CAGR 4.74% to reach USD 3,299.16 million by 2027.
• The Asia-Pacific Transdermal Drug Delivery System Market size was estimated at USD 1,670.92 million in 2021 and expected to reach USD 1,762.80 million in 2022, at a CAGR 5.17% to reach USD 2,261.22 million by 2027.
• The Europe, Middle East & Africa Transdermal Drug Delivery System Market size was estimated at USD 2,200.34 million in 2021 and expected to reach USD 2,297.37 million in 2022, at a CAGR 4.81% to reach USD 2,917.67 million by 2027.

Market Segmentation & Coverage:

The report on transdermal drug delivery system identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the transdermal drug delivery system to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

• Transdermal Patches
  • Drug-In-Adhesive Patches
  • Matrix Patches
  • Microneedle Patches
  • Reservoir Membrane Patches
• Transdermal Semisolids
  • Gels
  • Ointments
  • Sprays

Application:

• Cardiovascular Diseases
• Central Nervous System Disorders
• Hormonal Applications
• Pain Management
• Transdermal Estrogen Therapy

End User:

• Home Care Settings
• Hospitals & Clinics

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• 3M Company
• Bayers AG
• Boehringer Ingelheim International GmbH
• Endo International, Inc.
• Glaxosmithkline PLC
• Hisamitsu Pharmaceutical Co., Inc.
• IBSA Farmaceutici Italia Srl
• Johnson & Johnson
• Katecho, LLC
• Lavipharm S.A.
• Lead Chemical Co.,Ltd.
• Luye Pharma Group
• Manchester BIOGEL
• Nitto Denko Corporation
• Novartis International AG
• Nutriband Inc.
• Sparsha Pharma International Pvt. Ltd.
• UCB S.A.
• Viatris Inc.

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 6,369.32 million

Estimated Year Value: USD 6,663.09 million

Forecast Year Value: USD 8,478.05 million

CAGR (%): 4.88%.

Please Note: PDF & Excel + Online Access - 1 Year